3-aminobenzamide has been researched along with Melanoma in 9 studies
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boon, MH | 1 |
| Parsons, PG | 1 |
| Malorni, W | 2 |
| Rivabene, R | 2 |
| Straface, E | 2 |
| Rainaldi, G | 2 |
| Monti, D | 2 |
| Salvioli, S | 1 |
| Cossarizza, A | 2 |
| Franceschi, C | 2 |
| Capri, M | 1 |
| Lönn, U | 3 |
| Lönn, S | 3 |
| He, YJ | 1 |
| Liu, RH | 1 |
| Ning, CQ | 1 |
| Yu, NF | 1 |
| Bedikian, AY | 1 |
| Papadopoulos, NE | 1 |
| Kim, KB | 1 |
| Hwu, WJ | 1 |
| Homsi, J | 1 |
| Glass, MR | 1 |
| Cain, S | 1 |
| Rudewicz, P | 1 |
| Vernillet, L | 1 |
| Hwu, P | 1 |
| Toshimitsu, H | 1 |
| Yoshimoto, Y | 1 |
| Augustine, CK | 1 |
| Padussis, JC | 1 |
| Yoo, JS | 1 |
| Angelica Selim, M | 1 |
| Pruitt, SK | 1 |
| Friedman, HS | 1 |
| Ali-Osman, F | 1 |
| Tyler, DS | 1 |
1 review available for 3-aminobenzamide and Melanoma
| Article | Year |
|---|---|
[Research progresses of the PARP inhibitors for the treatment of cancer].
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combinat | 2013 |
1 trial available for 3-aminobenzamide and Melanoma
| Article | Year |
|---|---|
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Ch | 2009 |
7 other studies available for 3-aminobenzamide and Melanoma
| Article | Year |
|---|---|
Cyclophosphamide resistance developed in a human melanoma cell line.
Topics: Benzamides; Caffeine; Cell Line; Cross-Linking Reagents; Cyclophosphamide; Drug Resistance; Humans; | 1984 |
3-Aminobenzamide protects cells from UV-B-induced apoptosis by acting on cytoskeleton and substrate adhesion.
Topics: Animals; Apoptosis; Benzamides; Cell Adhesion; Cell Line; Cells, Cultured; Cytoskeleton; Epithelium; | 1995 |
3-Aminobenzamide induces cytoskeleton rearrangement in M14 melanoma cells.
Topics: Benzamides; Cell Division; Cytoskeleton; Humans; Melanoma; Microscopy, Electron, Scanning; Microscop | 1994 |
Step-wise progression of mammalian 10-kb DNA replication intermediates to mature chromatin.
Topics: Benzamides; Cell Line; Chromatin; DNA Replication; DNA, Neoplasm; Endonucleases; Humans; Melanoma; P | 1988 |
Accumulation of 10-kilobase DNA replication intermediates in cells treated with 3-aminobenzamide.
Topics: Aphidicolin; Benzamides; Cell Line; Diterpenes; DNA Replication; DNA, Single-Stranded; Humans; Inter | 1985 |
Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity.
Topics: Antineoplastic Agents; Aphidicolin; Benzamides; Cell Line; Dacarbazine; Diterpenes; DNA; DNA Repair; | 1987 |
Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarb | 2010 |